HAEMONETICS CORP/MASS (HAE) Stock Cash Flow
USA - New York Stock Exchange - NYSE:HAE - US4050241003 - Common Stock
80.58 USD
-0.05 (-0.06%)
| TTM (2025-9-27) | 2025 (2025-3-29) | 2024 (2024-3-30) | 2023 (2023-4-1) | 2022 (2022-4-2) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 168.19M | 167.68M | 117.56M | 115.40M | 43.40M | |||
| Depreciation Amortization | 114.25M | 115.59M | 97.22M | 93.30M | 97.70M | |||
| Income Taxes - Deferred | -3.00M | -5.22M | -11.04M | 4.80M | 5.00M | |||
| Change In Working Capital | -18.94M | -101.96M | -74.70M | 25.50M | -15.20M | |||
| Interest Paid | N/A | 16.53M | 20.90M | 13.60M | 6.20M | |||
| Taxes Paid | N/A | 49.29M | 52.71M | 18.00M | 24.30M | |||
| Other non cash items | 28.54M | 5.64M | 52.72M | 34.10M | 41.30M | |||
| OPERATING CASH FLOW | 289.04M | 181.72M | 181.75M | 273.10M | 172.30M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -76.47M | -60.39M | -66.30M | -110.20M | -96.50M | |||
| Other Investing Activity | 13.67M | -101.50M | -256.09M | -33.60M | 10.20M | |||
| INVESTING CASH FLOW | -62.80M | -161.90M | -322.39M | -143.80M | -86.30M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -6.25M | 447.31M | 37.75M | -9.60M | -17.50M | |||
| Stock Issued/Repurchased | -217.32M | -216.67M | 7.21M | -68.00M | 6.50M | |||
| Other Financing Activity | -5.50M | -121.83M | -6.81M | -22.80M | -4.80M | |||
| FINANCING CASH FLOW | -229.06M | 108.82M | 38.16M | -100.40M | -15.70M | |||
| Exchange Rate Effect | -33.00K | -685.00K | -3.19M | -3.90M | -3.00M | |||
| CHANGE IN CASH | -2.86M | 127.96M | -105.67M | 25.00M | 67.30M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 289.04M | 181.72M | 181.75M | 273.10M | 172.30M | |||
| Capital Expenditure | -76.47M | -60.39M | -66.30M | -110.20M | -96.50M | |||
| FREE CASH FLOW | 212.57M | 121.33M | 115.45M | 162.90M | 75.80M | |||
All data in USD